Announcements
PSMID is pleased to share the newest SPOTLIGHTS features of the Philippines and Malaysia highlighting the unique Network structures of the two newest QIS+D countries from Southeast Asia.
PSMID is part of a national collaboration with the Sustained Health Initiatives of the Philippines (SHIP) to reduce HIV-related stigma and discrimination in healthcare settings.
Videos
PSMID-SHIP-UCSF : Meaningful Involvement of PLHIV in Healthcare
Lay Forum and Launch of the Philippine HIV Stigma & Discrimination Reduction QI Learning Network
December 1, 2020
Chair: Katerina Leyritana, MD, FPCP, FPSMID
Videos
Industry-Sponsored Lecture (Sandoz)
TB+HIV Updates
Speakers:
Daniel Tan, MD, FPCP
Rontgene M. Solante, MD, FPCP, FPSMID
Videos
Industry-Sponsored Lecture (Camber)
Clinical Advances in the management of HIV guidelines and New Evidence
Speaker: Joseph Perriëns, MD, PhD
University of Ghent, Belgium
Clinical Practice Guidelines
The objective of this guideline is to provide a framework for the treatment of Filipino HIV patients using an evidence-based approach, with emphasis on locally available treatment. The target audience is not only the infectious diseases subspecialist who treats HIV but also internists, family physicians, pulmonary specialists and other subspecialists who are taking care of or who wish to care for persons living with HIV.
Clinical Practice Guidelines
Guidance on the management of HIV-infected healthcare workers in the Philippines. Recommendations to guide physicians and hospital administrators involved in the management of HIV-infected healthcare workers.
The main objective of this paper is to provide an ethical and legal framework in managing the HIV-infected healthcare worker, balancing the rights and safety of both the patient and the healthcare provider.
The Philippine Society for Microbiology and Infectious Diseases (PSMID) Guidance on the Management of Mpox, Ver. 1 provides the basic and most updated information on management of patients confirmed with mpox.
This guidance complements the mpox recommendations of the DOH (Updated Interim Guidelines on the Prevention, Detection, and Management of MPOX, by Department of Health, August 26, 2024, Department Memorandum 2024-0306) and PHICS-PHICNA (Interim Guidelines on the Prevention and Control of Monkeypox version 1).
The antivirals, immunoglobulin and vaccines discussed below are not available locally. In our local situation, we should maximize supportive care for mpox cases.